Research Article
Antioxidant and Antibacterial Effects of Pollen Extracts on Human Multidrug-Resistant Pathogenic Bacteria
Table 2
Antibacterial activities of standard antibiotics.
| | Acinetobacter baumannii | Enterobacter cloacae | Escherichia coli | Klebsiella pneumoniae | Pseudomonas aeruginosa | Staphylococcus aureus | | Antibiotic used | Inhibition zone (mm) | Antibiotic used | Inhibition zone (mm) | Antibiotic used | Inhibition zone (mm) | Antibiotic used | Inhibition zone (mm) | Antibiotic used | Inhibition zone (mm) | Antibiotic used | Inhibition zone (mm) |
| | TZP | 27 ± 0.54 (S) | AMP | 6 ± 0 (R) | AMC | 6 ± 0 (R) | AMC | 11 ± 0 (R) | TIC | 11 ± 0.21 (R) | FOX | 30 ± 0.54 (S) | | TIC | 27 ± 0.22 (S) | AMC | 12 ± 0.11 (R) | CAZ | 31 ± 0.52 (S) | CAZ | 36 ± 0.78 (S) | PRL | 10 ± 0 (R) | MY | 30 ± 0.22(S) | | CAZ | 24 ± 0.56 (S) | CAZ | 17 ± 0.63 (I) | CTX | 35 ± 0.42 (S) | CTX | 40 ± 0.65 (S) | CAZ | 10 ± 0 (R) | FOS | 46 ± 0.55 (S) | | PRL | 25 ± 0.62 (S) | CTX | 9 ± 0 (R) | IPM | 32 ± 0.54 (S) | IPM | 38 ± 0.32 (S) | TOB | 22 ± 0.26 (S) | FD | 8 ± 0 (R) | | IPM | 33 ± 0.77 (S) | FOX | 11 ± 0.12 (R) | AMP | 6 ± 0 (R) | AMP | 6 ± 0 (R) | CS | 16 ± 0.87 (I) | P | 18 ± 0.54 (I) | | TOB | 26 ± 0 (S) | KF | 6 ± 0 (R) | NA | 26 ± 0 (S) | NA | 30 ± 0.69 (S) | CIP | 34 ± 0.69 (S) | E | 28 ± 0.25 (S) | | AK | 25 ± 0.15 (S) | ETP | 31 ± 0.85 (S) | CN | 20 ± 0.52 (S) | CN | 19 ± 0 (I) | CN | 18 ± 0.77 (I) | CN | 30 ± 0.35 (S) | | CN | 25 ± 0.82 (S) | CN | 10 ± 0.54 (R) | FOX | 26 ± 0.12 (S) | FOX | 31 ± 0.21(S) | AK | 23 ± 0.25 (S) | RD | 34 ± 0.85 (S) | | CIP | 30 ± 0.42 (S) | AK | 23 ± 0.10 (S) | NOR | 31 ± 0.45 (S) | NOR | 33 ± 0.52 (S) | ETP | 21 ± 0.36 (S) | | | | SXT | 27 ± 0.14 (S) | PEF | 6 ± 0 (R) | FOS | 27 ± 0.98 (S) | FOS | 37 ± 0.32(S) | | | | | | | | CIP | 6 ± 0 (R) | | | | | | | | | | | | NA | 6 ± 0 (R) | | | | | | | | | | | | SXT | 6 ± 0 (R) | | | | | | | | | | | | FOS | 28 ± 0.25 (S) | | | | | | | | |
|
|
AMC: amoxicillin + clavulanic acid (20 + 10 μg/disc); AK: amikacin (30 μg/disc); AMP: ampicillin (10 μg/disc); CAZ: ceftazidime (30 μg/disc); CIP: ciprofloxacin (5 μg/disc); CN: gentamicin (10 μg/disc); CS: colistin (30 μg/disc); CTX: cefotaxime (30 μg/disc); E: erythromycin (15 μg/disc); ETP: ertapenem (10 μg/disc); FD: fusidic acid (10 μg/disc); FOS: fosfomycin (50 μg/disc); FOX: cefoxitin (30 μg/disc); IPM: imipenem (10 μg/disc); KF: cephalothin (30 μg/disc); MY: lincomycin (15 μg/disc); NA: nalidixic acid (30 μg/disc); NOR: norfloxacin (10 μg/disc); P: penicillin G (10 μg/disc); PEF: pefloxacin (5 μg/disc); PRL: piperacillin (100 μg/disc); RD: rifampicin (30 μg/disc); SXT: trimethoprim + sulfamethoxazole (1.25 + 23.75 μg/disc); TEC: teicoplanin (30 μg/disc); TIC: ticarcillin (75 μg/disc); TOB: tobramycin (10 μg/disc); TZP: piperacillin + tazobactam (30 + 6 μg/disc); VA: vancomycin (30 μg/disc); (R): resistant; (S): susceptible; (I): intermediate.
|
